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Aspergillosis is the group of diseases caused by the Aspergillus species, which cause a broad spectrum of
disease, ranging from hypersensitivity reactions to direct angioinvasion. The major forms of pulmonary
aspergillosis range from aspergilloma with a relatively benign course to invasive pulmonary aspergillosis,
which is uniformly fatal. Invasive pulmonary aspergillosis more commonly occurs in immunocompro-
mised patients, with a rapidly progressing course leading to death. We report a case of an immuno-
competent patient who developed fatal pneumonia secondary to Aspergillus fumigatus.
 2011 Elsevier Ltd. All rights reserved.Pulmonary aspergillosis usually produces a wide spectrum of
lung disease, ranging from aspergilloma with a relatively benign
course, to invasive pulmonary aspergillosis, which is uniformly
fatal. Invasive pulmonary aspergillosis usually occurs in immuno-
compromised patients, with a rapidly progressing course that leads
to death. We herein report a case of an immunocompetent patient
who developed fatal pneumonia secondary to Aspergillus fumigatus.
1. Case presentation
A 25 year-old Hispanic male with a history of pulmonary
tuberculosis was admitted to the hospital secondary to gunshot
wounds to the abdomen and leg. The patient was alert, awake, and
completely oriented upon arrival. His vital signs were stable.
Examination of the chest, cardiovascular system, and abdomen
were unremarkable, except that he had one entry and exit wound
in the left lower quadrant of the abdomen from the gunshot. He did
not have any signs of peritonitis. Chest x-ray on admission revealed
a cavitary lung lesion on the right upper lobe. All other examina-
tions and laboratory tests were within normal limits. On further
questioning, the patient revealed that he was treated for pulmo-
nary tuberculosis in the past. Patient denied any illicit drug use,
alcohol abuse or smoking.
The patient underwent successful surgical exploration of the
abdomen and was placed on mechanical ventilation post-opera-
tively. Thepatientwas recoveringwelluntil day3of admission,whenb).
. Pathak), samarahurtado@
86.
rved.he developed tachycardia and tachypnea and became febrile while
still on the mechanical ventilator. His total leukocyte count had
increased signiﬁcantly with a left shift. Repeat chest x-ray showed
new bilateral pulmonary inﬁltrates. Multiple broad spectrum anti-
biotics were started to treat ventilator-associated pneumonia;
however, the patient continued to be hypoxic, requiring a high
oxygen concentration and high positive end expiratory pressure
(PEEP). Since his clinical status did not improve despite treatment
with multiple broad spectrum antibiotics, a computed tomography
(CT) scan of the chest was done. The chest CT showed bilateral upper
lobe cavitary lesions with nodular enhancement and layering ﬂuid/
debris. It also showed pulmonary nodular opacities in the broncho-
vascular distribution. A sputum culture grew A. fumigatus. Human
immunodeﬁciency virus (HIV) test was negative. The patient was
started on anti-fungal treatment, but he died two weeks after intu-
bation. The patient was accepted for autopsy, and the autopsy result
conﬁrmed the diagnosis of invasive pulmonary aspergillosis.2. Discussion
Some Aspergillus species cause a broad spectrum of disease in
humans, ranging from hypersensitivity reactions to direct angioin-
vasion. Aspergillus primarily affects the lungs, causing four main
syndromes, including allergic bronchopulmonary aspergillosis
(ABPA), chronic necrotizing pneumonia, aspergilloma, and invasive
aspergillosis. Usually, only immunocompromised patients or those
who suffer other chronic lung conditions are susceptible. Immu-
nocompetent patients are normally asymptomatic and only inci-
dentally are they found to have aspergilloma in a preexisting cavity,
bulla, or cyst.1e3 However, there have been rare cases where an
immunocompetent patient had an invasive form of aspergillosis.4
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indistinguishable from bacterial or viral pneumonia. The most
common presenting symptoms are fever, cough, dyspnea, and ﬂu-
like symptoms.5e13 The most common chest radiographic abnor-
malities in these patients are bilateral diffuse chest inﬁltrates.
Patients can also have cavitary lung lesions on presentation, with
some developing cavity a few days later. The presence of cavity on
admission usually points toward the diagnosis of aspergillosis, but
it is not speciﬁc.4e13 Because of its non-speciﬁc nature, the median
time from onset of symptoms to presumptive diagnosis is two
weeks. These cases are found to be uniformly fatal4e11 due to delay
in the diagnosis.The deﬁnitive diagnosis of invasive pulmonary aspergillosis is
made when the fungus growth is demonstrated within tissue upon
biopsy. Positive sputum cultures are not necessarily reliable for
diagnosis because Aspergillus is frequently a contaminant in
sputum. However, given that invasive aspergillosis has a 100%
mortality rate, a respiratory secretion culture positive for Asper-
gillus should not be routinely dismissed as a contaminant.4 The
longer the delay in diagnosis and treatment, the more likely it is
that anti-fungal treatment will be ineffective and the outcome will
be fatal.
3. Conclusion
Invasive pulmonary aspergillosis should be included in the
differential diagnoses for a patient presenting with diffuse bilateral
chest inﬁltrates, with or without cavity. Any indication of asper-
gillosis, by positive sputum culture or lack of response to routine
antibiotic therapy, should compel the physician to conduct a lung
biopsy and initiate anti-fungal treatment.
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